Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

LEVOCETIRIZINE DIHYDROCHLORIDE

FDA · NDA · 2026-05-20

AgencyFDA
Submission typeNDA
Action date2026-05-20
BrandXYZAL ALLERGY 24HR
SponsorCHATTEM SANOFI
RouteORAL

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T03:31:05.514Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:LEVOCETIRIZINE DIHYDROCHLORIDE:2026-05-20

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

LEVOCETIRIZINE DIHYDROCHLORIDE — approval | AEaH